Follow us on Twitter

Friday 27 April 2012

MicroDose Therapeutx Announces Conclusion of MDT-637 Phase I Single and Multiple Ascending Dose Studies in Healthy Volunteers for Treatment of Respiratory Syncytial Virus (RSV) - MarketWatch

http://www.marketwatch.com/story/microdose-therapeutx-announces-conclusion-of-mdt-637-phase-i-single-and-multiple-ascending-dose-studies-in-healthy-volunteers-for-treatment-of-respiratory-syncytial-virus-rsv-2012-04-24

No comments:

Post a Comment